EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo

Anindita Banerjee iD, Khaled Ezzedine, Ronald Shore, Elena Peeva, Yuji Yamaguchi, Lori Cox, Abigail Sloan, Margaret Gamalo, Christian Russel Reyes

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljad436 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Anindita Banerjee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer, Inc., Cambridge, MA, USA. Hauptthemen laut MEDLINE: Vitiligo, Observer Variation, Severity of Illness Index. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With several vitiligo therapies currently under development, a reliable clinician-reported outcome is needed to assess disease severity and treatment response. The objective of the current study was to evaluate the inter- and intra-rater reliabilities of the F-VASI in assessing the extent and severity of vitiligo in a central reader paradigm as part of a clinical trial of the oral dual Janus kinase 3/Tec family kinase inhibitor ritlecitinib in patients with vitiligo. We found strong and consistent inter-rater agreement between two central readers across all F-VASI measurements and observed similar reliability for intra-rater assessments across two separate readings of the same patient images.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoObserver VariationSeverity of Illness IndexHumansAdultFemaleMaleMiddle AgedFacial DermatosesYoung AdultReproducibility of Results

Autor:innen und Institutionen

  • Pfizer, Inc., Cambridge, MA, USA.
  • Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
  • Ronald N. Shore Dermatology, Rockville, MD, USA.
  • Pfizer, Inc., Collegeville, PA, USA.
  • Consultant to Pfizer, Basking Ridge, NJ, USA.
  • Pfizer, Inc., Makati City, Philippines.

ORCID-Profile: Anindita Banerjee

Förderung

  • Pfizer, Inc

Zitieren

APA

Banerjee, A., Ezzedine, K., Shore, R., Peeva, E., Yamaguchi, Y., Cox, L., Sloan, A., Gamalo, M., & Reyes, C. R. (2024). An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad436

Vancouver

Banerjee A, Ezzedine K, Shore R, Peeva E, Yamaguchi Y, Cox L, et al. An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljad436

BibTeX
@article{Banerjee2024,
  author = {Banerjee, Anindita and Ezzedine, Khaled and Shore, Ronald and Peeva, Elena and Yamaguchi, Yuji and Cox, Lori and Sloan, Abigail and Gamalo, Margaret and Reyes, Christian Russel},
  title = {An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljad436}
}
Kostenlos starten →